762275-96-7

Upstream product

• 552-41-0 1-(2-hydroxy-4-methoxyphenyl)ethanone 
• 52249-86-2 2-benzyloxy-4-methoxyacetophenone 
• 198209-31-3 2-bromo6-(2,5-dimethyl-pyrrol-1-yl)-pyridine 
• 1019636-96-4 C₂₀H₂₉BO₅Si 
• 762275-95-6 2-benzyloxy-5-bromo-1-t-butyldimethylsilyloxy4-methoxybenzene 
• 100-39-0 benzyl bromide 

Downstream Products

• 762275-97-8 2-(4-benzyloxy-2,5-dimethoxy-phenyl)-6-(2,5-dimethyl-pyrrol-1-yl)-pyridine 
• 762275-98-9 4-(6-amino-pyridin-2-yl)-2,5-dimethoxy-phenol 
• 1019636-97-5 2-(4-benzyloxy-5-hydroxy-2-methoxy-phenyl)-6-(2,5-dimethyl-pyrrol-1-yl)-pyridine 

Relevant academic research and scientific papers

Substituted 6-phenyl-pyridin-2-ylamines: Selective and potent inhibitors of neuronal nitric oxide synthase

The synthesis and nNOS and eNOS activity of 6-(4-(dimethylaminoalkyl)-/6- (4-(dimethylaminoalkoxy)-5-ethyl-2-methoxyphenyl)-pyridin-2-ylamines and 6-(4-(dimethylaminoalkyl)-/6-(4-(dimethylaminoalkoxy)-2,5-dimethoxyphenyl) -pyridin-2-ylamines 1-8 are described. These compounds are potent inhibitors of the human nNOS isoform.

2-AMINO-6-(2-SUBSTITUTED-4-PHENOXY)-SUBSTITUTED-PYRIDINES

This present invention relates to compounds of the formula wherein G, R1 and R2 are defined as in the specification, to pharmaceutical compositions containing them and to their use in the treatment and prevention of central nervous system and other disorders.